Brazil pharma growth faces data protection challenges
Brazil's General Data Protection Legislation will raise issues for participation in global pharmaceutical research
You must be signed in to read this analysis
In this article
- Health framework: overlapping mandates
- International data transfers
- Research ethics and data protection
- Innovation and artificial intelligence (AI)
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.
